0

Close
 
Upcoming Allied Market Research
2023
Lumpectomy Market

Lumpectomy Market

by Product (Surgical Tools, Lumpectomy Systems) and by End User (Hospitals, Clinics, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare
Report Code: A03362
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Lumpectomy Market

Request Now !

Lumpectomy is also known as wide local excision or breast-conserving surgery. Unlike mastectomy, only a portion of the breast is removed in this procedure. Doctors may also refer to lumpectomy as an excisional biopsy. Lumpectomy helps in confirming diagnosis and complete absence of cancer. It is also the premiere treatment option for some women with early-stage breast cancer.

Increase in usage of mammography for early breast cancer detection, surge in prevalence of breast cancer, and rise in government initiatives to raise public awareness of breast cancer boost the global lumpectomy market. However, stringent government regulations related to lumpectomy testing systems impede this growth.

The global lumpectomy market is segmented on the basis of product, end user, and region. Based on product, it is bifurcated into surgical tools and lumpectomy systems Furthermore, on the basis of end user, it is categorized into hospitals, clinics, and ambulatory surgical centers. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major players, such Sanarus, ClearCut Medical, Vector Surgical, Dune Medical Devices, Medtronic PLC, ZEISS, iCAD, Hologic, Inc., and Novian Health, Inc., are provided in this report.

Key Benefits

  • The study provides an in-depth analysis of the global lumpectomy market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the major opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
  • Extensive analysis by product elucidates the use of lumpectomy devices in the medical settings.

 Lumpectomy Market Report Highlights

Aspects Details
By Product
  • Surgical Tools
  • Lumpectomy Systems
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Turkey, Rest of LAMEA)
Key Market Players Sanarus,, Medtronic PLC, ZEISS,, ClearCut Medical,, Dune Medical Devices,, Hologic, Novian Health, Inc, iCAD,, Hologic, Inc., Vector Surgical,
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: LUMPECTOMY MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Surgical Tools

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Lumpectomy Systems

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: LUMPECTOMY MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ambulatory Surgical Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: LUMPECTOMY MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Lumpectomy Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Lumpectomy Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Lumpectomy Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Lumpectomy Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Lumpectomy Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Lumpectomy Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Lumpectomy Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Lumpectomy Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Lumpectomy Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Lumpectomy Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Lumpectomy Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Lumpectomy Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Lumpectomy Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Lumpectomy Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Lumpectomy Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Lumpectomy Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Lumpectomy Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Lumpectomy Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Lumpectomy Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Lumpectomy Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Lumpectomy Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Lumpectomy Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Lumpectomy Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Lumpectomy Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Lumpectomy Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Sanarus,

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. ClearCut Medical,

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Vector Surgical,

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Dune Medical Devices,

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Medtronic PLC

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. ZEISS,

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. ICAD,

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Hologic, Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Novian Health, Inc

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Hologic

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LUMPECTOMY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL LUMPECTOMY MARKET FOR SURGICAL TOOLS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL LUMPECTOMY MARKET FOR LUMPECTOMY SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL LUMPECTOMY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL LUMPECTOMY MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL LUMPECTOMY MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL LUMPECTOMY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL LUMPECTOMY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA LUMPECTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. U.S. LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 13. U.S. LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. CANADA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. CANADA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE LUMPECTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. FRANCE LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. FRANCE LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. GERMANY LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. ITALY LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. ITALY LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. UK LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. UK LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. RUSSIA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. RUSSIA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC LUMPECTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. CHINA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. CHINA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. INDIA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. INDIA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. THAILAND LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. THAILAND LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. MALAYSIA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. MALAYSIA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. INDONESIA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. INDONESIA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. LAMEA LUMPECTOMY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. LAMEA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. BRAZIL LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. BRAZIL LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. SOUTH AFRICA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH AFRICA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SAUDI ARABIA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. SAUDI ARABIA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. UAE LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. UAE LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ARGENTINA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. ARGENTINA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. REST OF LAMEA LUMPECTOMY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. REST OF LAMEA LUMPECTOMY, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. SANARUS,: KEY EXECUTIVES
  • TABLE 72. SANARUS,: COMPANY SNAPSHOT
  • TABLE 73. SANARUS,: OPERATING SEGMENTS
  • TABLE 74. SANARUS,: PRODUCT PORTFOLIO
  • TABLE 75. SANARUS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. CLEARCUT MEDICAL,: KEY EXECUTIVES
  • TABLE 77. CLEARCUT MEDICAL,: COMPANY SNAPSHOT
  • TABLE 78. CLEARCUT MEDICAL,: OPERATING SEGMENTS
  • TABLE 79. CLEARCUT MEDICAL,: PRODUCT PORTFOLIO
  • TABLE 80. CLEARCUT MEDICAL,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. VECTOR SURGICAL,: KEY EXECUTIVES
  • TABLE 82. VECTOR SURGICAL,: COMPANY SNAPSHOT
  • TABLE 83. VECTOR SURGICAL,: OPERATING SEGMENTS
  • TABLE 84. VECTOR SURGICAL,: PRODUCT PORTFOLIO
  • TABLE 85. VECTOR SURGICAL,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. DUNE MEDICAL DEVICES,: KEY EXECUTIVES
  • TABLE 87. DUNE MEDICAL DEVICES,: COMPANY SNAPSHOT
  • TABLE 88. DUNE MEDICAL DEVICES,: OPERATING SEGMENTS
  • TABLE 89. DUNE MEDICAL DEVICES,: PRODUCT PORTFOLIO
  • TABLE 90. DUNE MEDICAL DEVICES,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 92. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 93. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 94. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 95. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. ZEISS,: KEY EXECUTIVES
  • TABLE 97. ZEISS,: COMPANY SNAPSHOT
  • TABLE 98. ZEISS,: OPERATING SEGMENTS
  • TABLE 99. ZEISS,: PRODUCT PORTFOLIO
  • TABLE 100. ZEISS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. ICAD,: KEY EXECUTIVES
  • TABLE 102. ICAD,: COMPANY SNAPSHOT
  • TABLE 103. ICAD,: OPERATING SEGMENTS
  • TABLE 104. ICAD,: PRODUCT PORTFOLIO
  • TABLE 105. ICAD,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. HOLOGIC, INC.: KEY EXECUTIVES
  • TABLE 107. HOLOGIC, INC.: COMPANY SNAPSHOT
  • TABLE 108. HOLOGIC, INC.: OPERATING SEGMENTS
  • TABLE 109. HOLOGIC, INC.: PRODUCT PORTFOLIO
  • TABLE 110. HOLOGIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. NOVIAN HEALTH, INC: KEY EXECUTIVES
  • TABLE 112. NOVIAN HEALTH, INC: COMPANY SNAPSHOT
  • TABLE 113. NOVIAN HEALTH, INC: OPERATING SEGMENTS
  • TABLE 114. NOVIAN HEALTH, INC: PRODUCT PORTFOLIO
  • TABLE 115. NOVIAN HEALTH, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. HOLOGIC: KEY EXECUTIVES
  • TABLE 117. HOLOGIC: COMPANY SNAPSHOT
  • TABLE 118. HOLOGIC: OPERATING SEGMENTS
  • TABLE 119. HOLOGIC: PRODUCT PORTFOLIO
  • TABLE 120. HOLOGIC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LUMPECTOMY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LUMPECTOMY MARKET
  • FIGURE 3. SEGMENTATION LUMPECTOMY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LUMPECTOMY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLUMPECTOMY MARKET
  • FIGURE 11. LUMPECTOMY MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. LUMPECTOMY MARKET FOR SURGICAL TOOLS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. LUMPECTOMY MARKET FOR LUMPECTOMY SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. LUMPECTOMY MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. LUMPECTOMY MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. LUMPECTOMY MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. LUMPECTOMY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: LUMPECTOMY MARKET
  • FIGURE 24. Top player positioning, 2022
  • FIGURE 25. SANARUS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 26. SANARUS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 27. SANARUS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 28. CLEARCUT MEDICAL,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. CLEARCUT MEDICAL,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. CLEARCUT MEDICAL,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. VECTOR SURGICAL,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. VECTOR SURGICAL,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. VECTOR SURGICAL,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. DUNE MEDICAL DEVICES,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. DUNE MEDICAL DEVICES,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. DUNE MEDICAL DEVICES,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. ZEISS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. ZEISS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. ZEISS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. ICAD,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. ICAD,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. ICAD,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. HOLOGIC, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. HOLOGIC, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. HOLOGIC, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. NOVIAN HEALTH, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. NOVIAN HEALTH, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. NOVIAN HEALTH, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. HOLOGIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. HOLOGIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. HOLOGIC: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Lumpectomy Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers